{"id":11299,"date":"2026-07-12T22:40:22","date_gmt":"2026-07-13T02:40:22","guid":{"rendered":"https:\/\/acteraingredients.com\/?p=11299"},"modified":"2026-07-13T11:28:44","modified_gmt":"2026-07-13T15:28:44","slug":"trifarotene-and-rar-%ce%b3-what-makes-fourth-generation-retinoids-different","status":"publish","type":"learn","link":"https:\/\/acteraingredients.com\/fr\/learn\/trifarotene-and-rar-%ce%b3-what-makes-fourth-generation-retinoids-different\/","title":{"rendered":"Trifarot\u00e8ne et RAR-\u03b3 : ce qui diff\u00e9rencie les r\u00e9tino\u00efdes de quatri\u00e8me g\u00e9n\u00e9ration"},"content":{"rendered":"

For decades, the holy grail of retinoid chemistry has been to maximize skin renewal while completely eliminating irritation. First-generation retinoids (like retinol) fell short due to broad receptor binding. Third-generation retinoids (like adapalene) improved this drastically. However, it is the fourth generation<\/strong> that represents the pinnacle of dermatological precision, driven by a molecule called trifarotene.<\/p>\n

The Importance of the RAR-\u03b3 Receptor<\/h2>\n

To understand the fourth generation, we must understand the skin’s anatomy. The human body has three types of retinoic acid receptors (RAR-\u03b1, RAR-\u03b2, and RAR-\u03b3).<\/p>\n

While RAR-\u03b1 and RAR-\u03b2 are found in various tissues throughout the body, the RAR-\u03b3 (gamma) receptor is highly specific to the skin<\/strong>. In fact, RAR-\u03b3 accounts for over 90% of the retinoid receptors in the epidermis.<\/p>\n

Scientists realized that if they could engineer a molecule that ignored \u03b1 and \u03b2 entirely and only<\/em> bound to \u03b3, they could trigger powerful skin renewal at incredibly low concentrations, mitigating unnecessary collateral inflammation.<\/p>\n

Trifarotene: The Fourth-Generation Benchmark<\/h2>\n

Trifarotene is the first and only fourth-generation retinoid. It is characterized by its ultra-selective binding exclusively to the RAR-\u03b3 receptor. Because of this extreme precision, trifarotene requires a significantly lower concentration to achieve profound visible results in skin texture, tone, and clarity compared to earlier generations.<\/p>\n

Bringing Fourth-Generation Tech to Cosmetics: Trifarotol\u00ae<\/h2>\n

Trifarotene is a highly restricted prescription drug, making it off-limits for cosmetic skincare brands. However, utilizing advanced prodrug technology, Actera has bridged this gap with Trifarotol\u00ae (INCI: Trifarotenyl Caprylate)<\/strong><\/a>.<\/p>\n

    \n
  • How it Works:<\/strong> Trifarotol\u00ae is a cosmetic-grade esterification of the fourth-generation molecule. It remains inactive in the jar, ensuring supreme stability.<\/li>\n
  • Enzymatic Activation:<\/strong> Upon application, the skin’s esterases slowly break down the caprylate bond, providing a continuous, drip-feed activation of the RAR-\u03b3 pathway.<\/li>\n
  • Cosmetic Benefits:<\/strong> Clinical data<\/a> demonstrates that Trifarotol\u00ae accelerates skin renewal, diminishes the appearance of photoaging, and refines texture with a tolerability profile suitable for daily, non-prescription use.<\/li>\n<\/ul>\n

    By shifting to fourth-generation prodrugs, brands can market true “next-generation” retinoid science without running afoul of regulatory limits imposed on traditional Vitamin A.<\/p>\n

    Curious about how esterases activate these molecules? Read: Retinoid Prodrugs in Skincare: How Skin Enzymes Activate Next-Generation Actives<\/a><\/p>\n